About this trial
Considering that one out of five people may experience depression during the course of their life, and that compliance to anti-depression medication is often not optimal.
Psycho-educational interventions are recommended in international clinical practice guidelines for the management of depression. They are the first step in the treatment protocol.
Psychoeducation in the treatment of depressive episodes has been shown to be an effective intervention because it reduces depressive symptoms, the risk of relapse or recurrence and improves adherence to treatment.
In France, there are only one approved psycho-education programme, but it concerns a population of patients under psychiatric care.
No psycho-education programme has yet been carried out or evaluated in France on depressed patients followed up in primary care by their General Practitioner.
Recent changes in our healthcare practices, which have required adaptation to the pandemic context, have led to the development of the use of telemedicine.
This study aims to evaluate a new and 100% remote educational program adapted to patients ongoing moderate depression and focused on medication adherence, economic gain and patients and professional satisfaction.
Eligibility criteria
Qualifiers
Presenting a depressive episode of moderate intensity according to the Diagnostic and Statistical Manual (DSM)-V
With a prescription for an antidepressant started less than 2 months before inclusion in the trial.
Whose state of health is compatible with follow-up by their GP (possibility of occasional advice from a psychiatrist).
Have Internet access at home (computer) and are able to use the digital platform.
Disqualifiers
Patients who are unable to complete self-questionnaires (language barrier, etc.)
Who have already undergone a psycho-education or therapeutic patient education programme regarding depression.
Whose state of health requires follow-up by a psychiatrist
Trial design
Treatments tested in this trial
- psychoeducative program